Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE208567 |
Epigenetically-controlled tumor antigens derived from splice junctions between exons and transposable elements [ChIP-seq]
|
28 |
|
Sebastian Amigorena | Nov 22, 2022 | |||
GSE218085 |
Epigenetically-controlled tumor antigens derived from splice junctions between exons and transposable elements
|
133 |
|
Sebastian Amigorena | Nov 22, 2022 | |||
GSE201141 |
ATAC-seq after EBF1 degradation
|
8 |
|
Nikolay Zolotarev | Nov 22, 2022 | |||
GSE201142 |
ChIP after EBF1 degradation
|
8 |
|
Nikolay Zolotarev | Nov 22, 2022 | |||
GSE201143 |
Changes in gene expression after EBF1 degradation
|
8 | Nikolay Zolotarev | Nov 22, 2022 | ||||
GSE201144 |
EBF1 degradation in B Cells
|
20 |
|
Nikolay Zolotarev | Nov 22, 2022 |